Information Journal Paper
APA:
CopyZALI, HAKIMEH, GOLCHIN, ALI, FARAHANI, MASOUMEH, YAZDANI, MOHSEN, RANJBAR, Mohammad Mehdi, & DABBAGH, ALI. (2019). FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 18(3), 1639-1647. SID. https://sid.ir/paper/289166/en
Vancouver:
CopyZALI HAKIMEH, GOLCHIN ALI, FARAHANI MASOUMEH, YAZDANI MOHSEN, RANJBAR Mohammad Mehdi, DABBAGH ALI. FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2019;18(3):1639-1647. Available from: https://sid.ir/paper/289166/en
IEEE:
CopyHAKIMEH ZALI, ALI GOLCHIN, MASOUMEH FARAHANI, MOHSEN YAZDANI, Mohammad Mehdi RANJBAR, and ALI DABBAGH, “FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 18, no. 3, pp. 1639–1647, 2019, [Online]. Available: https://sid.ir/paper/289166/en